Biotech Values

[DewDiligence]

>> This is a two month old posting. <<

mid_swe, I was not trying to single you out in particular. Misconceptions about fast track and orphan status keep showing up frequently on various message boards, and I wanted to address that.

(For example, one of the posters on the OXGN board recently posted that fast track makes a drug more likely to be approved; as I replied there, exactly the opposite is true.)

>> Something is happening with OXGN. This weekend they started to look for a Senior Accountant. This is the 3:rd job in some weeks. <<

It looks like they are becoming less of a virtual company. Regards, Dew